Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.

Archives of internal medicine - 9 Jan 2006

Lim Seng Gee, Ng Tay Meng, Kung Nelson, Krastev Zahary, Volfova Miroslava, Husa Petr, Lee Samuel S, Chan Sing, Shiffman Mitchell L, Washington Mary Kay, Rigney Amy, Anderson Jane, Mondou Elsa, Snow Andrea, Sorbel Jeff, Guan Richard, Rousseau Franck

Abstract excerpt

BACKGROUND: Emtricitabine is a nucleoside analogue approved for treatment of human immunodeficiency virus 1 with clinical activity against hepatitis B virus (HBV). METHODS: To compare the safety and efficacy of emtricitabine with placebo in patients with HBV, we conducted a randomized (2:1), double-blind study at 34 sites in North America, Asia, and Europe that enrolled adults between November 2000 and July 2002...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Biopsy, Needle

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Deoxycytidine

Share to Double-Blind Method

Share to Emtricitabine

Share to Hepatitis B Antibodies

Share to Hepatitis B, Chronic

Share to Viral Load

Source

Identifiers

PMID: 16401810
DOI: 10.1001/archinte.166.1.49

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.PMID 16401810Read ↗

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.Semantic proximity Read ↗

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.Semantic proximity Read ↗

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionSemantic proximity Read ↗

Investigational RNA Interference Agents for Hepatitis BSemantic proximity Read ↗

Lamivudine as initial treatment for chronic hepatitis B in the United States.Semantic proximity Read ↗

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.Semantic proximity Read ↗

Telbivudine versus lamivudine in patients with chronic hepatitis B.Semantic proximity Read ↗

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.Semantic proximity Read ↗

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group.Semantic proximity Read ↗

Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA TherapeuticSemantic proximity Read ↗

Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.Semantic proximity Read ↗

Lamivudine for patients with chronic hepatitis B and advanced liver disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.